Bristol-Myers Squibb
BMY
#196
Rank
โ‚ฌ98.60 B
Marketcap
48,29ย โ‚ฌ
Share price
0.67%
Change (1 day)
24.11%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): 3,05ย โ‚ฌ

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is 3,03ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of 2,94ย โ‚ฌ an increase over its 2024 EPS that were of -3,76ย โ‚ฌ.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)3,05ย โ‚ฌ3.5%
20252,94ย โ‚ฌ-178.28%
2024-3,76ย โ‚ฌ-213.92%
20233,30ย โ‚ฌ30.2%
20222,53ย โ‚ฌ-6.04%
20212,70ย โ‚ฌ-179.29%
2020-3,40ย โ‚ฌ-281.37%
20191,88ย โ‚ฌ-27.21%
20182,58ย โ‚ฌ
20162,27ย โ‚ฌ175.26%
20150,83ย โ‚ฌ-19.83%
20141,03ย โ‚ฌ-22.44%
20131,33ย โ‚ฌ34.48%
20120,99ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
7,43ย โ‚ฌ 145.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
5,97ย โ‚ฌ 97.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
1,11ย โ‚ฌ-63.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
1,75ย โ‚ฌ-42.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
24,01ย โ‚ฌ 692.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
12,32ย โ‚ฌ 306.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
2,18ย โ‚ฌ-28.10%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
7,95ย โ‚ฌ 162.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
3,03ย โ‚ฌ-0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
5,91ย โ‚ฌ 95.22%๐Ÿ‡ฌ๐Ÿ‡ง UK